{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:13:08Z","timestamp":1789726388421,"version":"4.0.1"},"reference-count":268,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:00:00Z","timestamp":1706918400000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jaci.2022.09.030","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T16:52:46Z","timestamp":1669049566000},"page":"324-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Translating the biology of \u03b2 common receptor-engaging cytokines into clinical medicine"],"prefix":"10.1016","volume":"151","author":[{"given":"Harshita","family":"Pant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Hercus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon J.","family":"Tumes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok Ho","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Owczarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel F.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Huston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2022.09.030_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-065X.2012.01164.x","article-title":"The GM-CSF\/IL-3\/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling","volume":"250","author":"Broughton","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2022.09.030_bib2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.immuni.2019.03.022","article-title":"GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation","volume":"50","author":"Dougan","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.09.030_bib3","doi-asserted-by":"crossref","first-page":"a028514","DOI":"10.1101\/cshperspect.a028514","article-title":"Role of the \u03b2common (\u03b2c) family of cytokines in health and disease","volume":"10","author":"Hercus","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jaci.2022.09.030_bib4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jaci.2003.08.015","article-title":"Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF","volume":"112","author":"Martinez-Moczygemba","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.immunol.24.021605.090616","article-title":"Structural biology of shared cytokine receptors","volume":"27","author":"Wang","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101510","article-title":"IL-3 in the development and function of basophils","volume":"54","author":"Varricchi","year":"2021","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2022.104498","article-title":"IL-3 expands pre-basophil and mast cell progenitors by upregulating the IL-3 receptor expression","volume":"374","author":"Li","year":"2022","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood.V68.1.46.46","article-title":"Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hemopoiesis in normal adult mice","volume":"68","author":"Metcalf","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2021.10.009","article-title":"Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters","volume":"54","author":"Grzes","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.09.030_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/32190","article-title":"Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites","volume":"392","author":"Lantz","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2022.09.030_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.09.021","article-title":"Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases","volume":"51","author":"Cildir","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.09.030_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF01784044","article-title":"Differential response of human basophils and mast cells to recombinant chemokines","volume":"70","author":"Fureder","year":"1995","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jaci.2022.09.030_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/imm.13305","article-title":"IL-3 is essential for ICOS-L stabilization on mast cells, and sustains the IL-33-induced ROR\u03b3t(+) Treg generation via enhanced IL-6 induction","volume":"163","author":"Drube","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2022.09.030_bib14","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1002\/1521-4141(200208)32:8<2308::AID-IMMU2308>3.0.CO;2-X","article-title":"Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release","volume":"32","author":"Gebhardt","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib15","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0091-6749(96)70196-3","article-title":"Nonreleasing basophils convert to releasing basophils by culturing with IL-3","volume":"97","author":"Yamaguchi","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/intimm\/dxs103","article-title":"Plasmacytoid dendritic cells have a cytokine-producing capacity to enhance ICOS ligand-mediated IL-10 production during T-cell priming","volume":"25","author":"Ogata","year":"2013","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86131","article-title":"A cytotoxic anti-IL-3Ralpha antibody targets key cells and cytokines implicated in systemic lupus erythematosus","volume":"1","author":"Oon","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2022.09.030_bib18","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.4049\/jimmunol.167.11.6097","article-title":"IL-3 induces B7.2 (CD86) expression and costimulatory activity in human eosinophils","volume":"167","author":"Celestin","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.167.1.219","article-title":"Recombinant human interleukin 5 is a selective activator of human eosinophil function","volume":"167","author":"Lopez","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib20","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2022.09.030_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2022.09.030_bib22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","article-title":"Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial","volume":"149","author":"Bachert","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib23","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2020.09.054","article-title":"Benralizumab as a steroid-sparing treatment option in eosinophilic granulomatosis with polyangiitis","volume":"9","author":"Guntur","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.09.030_bib25","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jaci.2020.08.037","article-title":"Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a phase III, randomized, placebo-controlled trial","volume":"146","author":"Roufosse","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrrheum.2015.161","article-title":"Targeting GM-CSF in inflammatory diseases","volume":"12","author":"Wicks","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaci.2022.09.030_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/ITT.S262566","article-title":"GM-CSF: a promising target in inflammation and autoimmunity","volume":"9","author":"Lee","year":"2020","journal-title":"Immunotargets Ther"},{"key":"10.1016\/j.jaci.2022.09.030_bib29","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.4049\/jimmunol.1500871","article-title":"IL-3 Maintains activation of the p90S6K\/RPS6 pathway and increases translation in human eosinophils","volume":"195","author":"Esnault","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1182\/blood.V72.2.691.691","article-title":"Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in\u00a0vivo","volume":"72","author":"Socinski","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib31","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1038\/ncomms4039","article-title":"Integrin CD11b positively regulates TLR4-induced signalling pathways in dendritic cells but not in macrophages","volume":"5","author":"Ling","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2022.09.030_bib32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1074-7613(01)00218-7","article-title":"GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1","volume":"15","author":"Shibata","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.09.030_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-019-0066-3","article-title":"Pulmonary alveolar proteinosis","volume":"5","author":"Trapnell","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaci.2022.09.030_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13023-018-0846-y","article-title":"Prevalence and healthcare burden of pulmonary alveolar proteinosis","volume":"13","author":"McCarthy","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaci.2022.09.030_bib35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.8171324","article-title":"Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis","volume":"264","author":"Dranoff","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jaci.2022.09.030_bib36","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1073\/pnas.91.12.5592","article-title":"Granulocyte-macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology","volume":"91","author":"Stanley","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jaci.2022.09.030_bib37","doi-asserted-by":"crossref","first-page":"L438","DOI":"10.1152\/ajplung.00175.2021","article-title":"A murine model of hereditary pulmonary alveolar proteinosis caused by homozygous Csf2ra gene disruption","volume":"322","author":"Shima","year":"2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jaci.2022.09.030_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/1074-7613(95)90046-2","article-title":"Mice deficient for the IL-3\/GM-CSF\/IL-5 bc receptor exhibit lung pathology and impaired immune response, while bIL3 receptor-deficient mice are normal","volume":"2","author":"Nishinakamura","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.09.030_bib39","doi-asserted-by":"crossref","first-page":"9565","DOI":"10.1073\/pnas.92.21.9565","article-title":"Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5","volume":"92","author":"Robb","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.09.030_bib40","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.190.6.875","article-title":"Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor","volume":"190","author":"Kitamura","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib41","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.4049\/jimmunol.180.2.1199","article-title":"The IL-3\/IL-5\/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation","volume":"180","author":"Asquith","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/thx.2008.108290","article-title":"Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD","volume":"64","author":"Saha","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2022.09.030_bib43","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/annrheumdis-2016-210624","article-title":"A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis","volume":"76","author":"Burmester","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2022.09.030_bib44","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1172\/JCI113971","article-title":"Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions","volume":"83","author":"Xu","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.09.030_bib45","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.immuni.2015.08.010","article-title":"The cytokine GM-CSF drives the inflammatory signature of CCR2+ monocytes and licenses autoimmunity","volume":"43","author":"Croxford","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.09.030_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8880585","article-title":"Gene regulatory network of human GM-CSF-secreting T helper cells","volume":"2021","author":"Elias","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaci.2022.09.030_bib47","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1084\/jem.194.7.873","article-title":"Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis","volume":"194","author":"McQualter","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib48","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.4049\/jimmunol.1403243","article-title":"Expression of GM-CSF in T cells is increased in multiple sclerosis and suppressed by IFN-\u03b2 therapy","volume":"194","author":"Rasouli","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41577-020-0357-7","article-title":"GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches","volume":"20","author":"Lang","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib50","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20151853","article-title":"GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease","volume":"213","author":"Stock","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib51","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2022.09.030_bib52","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood.V86.7.2689.2689","article-title":"Regulation of granulocyte-macrophage colony-stimulating factor and E-selectin expression in endothelial cells by cyclosporin A\u00a0and the T-cell transcription factor NFAT","volume":"86","author":"Cockerill","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib53","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1073\/pnas.90.6.2466","article-title":"The GM-CSF\/IL3 locus is regulated by an inducible cyclosporin A\u00a0sensitive enhancer","volume":"90","author":"Cockerill","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.09.030_bib54","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1074-7613(00)80424-0","article-title":"A T cell-specific enhancer in the interleukin-3 locus is activated cooperatively by Oct and NFAT elements within a DNase I-hypersensitive site","volume":"6","author":"Duncliffe","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.09.030_bib55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev-immunol-051116-052350","article-title":"Th2 cells in health and disease","volume":"35","author":"Nakayama","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib56","doi-asserted-by":"crossref","first-page":"42399","DOI":"10.1074\/jbc.M205876200","article-title":"Identification of a conserved GATA3 response element upstream proximal from the interleukin-13 gene locus","volume":"277","author":"Yamashita","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2022.09.030_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba9953","article-title":"A distinct GM-CSF(+) T helper cell subset requires T-bet to adopt a TH1 phenotype and promote neuroinflammation","volume":"5","author":"Rasouli","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib58","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1006\/jmbi.1996.0337","article-title":"Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3","volume":"259","author":"Feng","year":"1996","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jaci.2022.09.030_bib59","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/363172a0","article-title":"A novel dimer configuration revealed by the crystal structure at 2.4\u00c5 resolution of human interleukin-5","volume":"363","author":"Milburn","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2022.09.030_bib60","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0022-2836(92)90470-5","article-title":"Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor","volume":"224","author":"Walter","year":"1992","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jaci.2022.09.030_bib61","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1107\/S1744309106016812","article-title":"An improved resolution structure of the human beta common receptor involved in IL-3, IL-5 and GM-CSF signalling which gives better definition of the high-affinity binding epitope","volume":"62","author":"Carr","year":"2006","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"10.1016\/j.jaci.2022.09.030_bib62","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0092-8674(01)00213-6","article-title":"Structure of the complete extracellular domain of the common beta subunit of the human GM-CSF, IL-3, and IL-5 receptors reveals a novel dimer configuration","volume":"104","author":"Carr","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2022.09.030_bib63","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41467-017-02633-7","article-title":"A dual role for the N-terminal domain of the IL-3 receptor in cell signalling","volume":"9","author":"Broughton","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2022.09.030_bib64","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/pro.2072","article-title":"Structural basis of interleukin-5 dimer recognition by its \u03b1receptor","volume":"21","author":"Kusano","year":"2012","journal-title":"Protein Sci"},{"key":"10.1016\/j.jaci.2022.09.030_bib65","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.str.2011.08.015","article-title":"Structure analysis of the IL-5 ligand-receptor complex reveals a wrench-like architecture for IL-5R\u03b1","volume":"19","author":"Patino","year":"2011","journal-title":"Structure"},{"key":"10.1016\/j.jaci.2022.09.030_bib66","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.str.2016.05.017","article-title":"Conformational changes in the GM-CSF receptor suggest a molecular mechanism for affinity conversion and receptor signaling","volume":"24","author":"Broughton","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.jaci.2022.09.030_bib67","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2022.09.030_bib68","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1002\/j.1460-2075.1995.tb07345.x","article-title":"Detailed analysis of the IL-5-IL-5R alpha interaction: characterization of crucial residues on the ligand and the receptor","volume":"14","author":"Cornelis","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.jaci.2022.09.030_bib69","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1002\/j.1460-2075.1989.tb08541.x","article-title":"Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor","volume":"8","author":"Gearing","year":"1989","journal-title":"EMBO J"},{"key":"10.1016\/j.jaci.2022.09.030_bib70","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0092-8674(91)90039-2","article-title":"Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors","volume":"66","author":"Kitamura","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2022.09.030_bib71","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cell.2007.12.030","article-title":"Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4\/13 system","volume":"132","author":"LaPorte","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2022.09.030_bib72","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.str.2010.01.003","article-title":"Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2","volume":"18","author":"Lupardus","year":"2010","journal-title":"Structure"},{"key":"10.1016\/j.jaci.2022.09.030_bib73","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1182\/blood.V89.3.842","article-title":"Roles of the N and C terminal domains of the interleukin-3 receptor alpha chain in receptor function","volume":"89","author":"Barry","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib74","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1074\/jbc.M808197200","article-title":"A new isoform of interleukin-3 receptor {alpha} with novel differentiation activity and high affinity binding mode","volume":"284","author":"Chen","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2022.09.030_bib75","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.celrep.2014.06.038","article-title":"Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibody","volume":"8","author":"Broughton","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2022.09.030_bib76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cyto.2007.12.010","article-title":"Slow-dissociation effect of common signaling subunit beta c on IL5 and GM-CSF receptor assembly","volume":"42","author":"Ishino","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2022.09.030_bib77","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.1074\/jbc.M309327200","article-title":"Kinetic interaction analysis of human interleukin 5 receptor alpha mutants reveals a unique binding topology and charge distribution for cytokine recognition","volume":"279","author":"Ishino","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2022.09.030_bib78","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1073\/pnas.92.24.10879","article-title":"Mutagenesis in the C-terminal region of human interleukin 5 reveals a central patch for receptor alpha chain recognition","volume":"92","author":"Morton","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.09.030_bib79","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1073\/pnas.92.11.5194","article-title":"Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist","volume":"92","author":"Tavernier","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.09.030_bib80","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/BJ20091745","article-title":"The Ig-like domain of human GM-CSF receptor alpha plays a critical role in cytokine binding and receptor activation","volume":"426","author":"Mirza","year":"2010","journal-title":"Biochem J"},{"key":"10.1016\/j.jaci.2022.09.030_bib81","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cell.2008.05.053","article-title":"The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation","volume":"134","author":"Hansen","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2022.09.030_bib82","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood-2002-06-1903","article-title":"Molecular assembly of the ternary granulocyte-macrophage colony-stimulating factor receptor complex","volume":"101","author":"McClure","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib83","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.91.1.252","article-title":"Histidine-367 of the human common beta chain of the receptor is critical for high-affinity binding of human granulocyte-macrophage colony-stimulating factor","volume":"91","author":"Lock","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.09.030_bib84","doi-asserted-by":"crossref","first-page":"26500","DOI":"10.1074\/jbc.M402705200","article-title":"Interleukin-3 binding to the murine betaIL-3 and human betac receptors involves functional epitopes formed by domains 1 and 4 of different protein chains","volume":"279","author":"Murphy","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2022.09.030_bib85","doi-asserted-by":"crossref","first-page":"10572","DOI":"10.1074\/jbc.M211664200","article-title":"A novel functional epitope formed by domains 1 and 4 of the human common beta-subunit is involved in receptor activation by granulocyte macrophage colony-stimulating factor and interleukin 5","volume":"278","author":"Murphy","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2022.09.030_bib86","doi-asserted-by":"crossref","first-page":"25999","DOI":"10.1074\/jbc.271.42.25999","article-title":"A single tyrosine residue in the membrane-proximal domain of the GM-CSF, IL-3 and IL-5 receptor common b-chain is necessary and sufficient for high affinity binding and signalling by all three ligands","volume":"271","author":"Woodcock","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2022.09.030_bib87","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1002\/j.1460-2075.1994.tb06848.x","article-title":"Three residues in the common b chain of the human GM-CSF, IL-3 and IL-5 receptors are essential for GM-CSF and IL-5 but not IL-3 high affinity binding and interact with Glu21 of GM-CSF","volume":"13","author":"Woodcock","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.jaci.2022.09.030_bib88","doi-asserted-by":"crossref","first-page":"31922","DOI":"10.1074\/jbc.271.50.31922","article-title":"A discontinuous eight-amino acid epitope in human interleukin-3 binds the a-chain of its receptor","volume":"271","author":"Bagley","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2022.09.030_bib89","doi-asserted-by":"crossref","first-page":"8488","DOI":"10.1016\/S0021-9258(17)37220-4","article-title":"Two contiguous residues in human interleukin-3, Asp21 and Glu22, selectively interact with the a- and b-chains of its receptor and participate in function","volume":"269","author":"Barry","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2022.09.030_bib90","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1073\/pnas.91.13.5838","article-title":"Specific human granulocyte-macrophage colony-stimulating factor antagonists","volume":"91","author":"Hercus","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.09.030_bib91","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1182\/blood-2008-12-164004","article-title":"The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease","volume":"114","author":"Hercus","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib92","doi-asserted-by":"crossref","first-page":"22630","DOI":"10.1074\/jbc.272.36.22630","article-title":"The receptor binding site of human interleukin-3 defined by mutagenesis and molecular modeling","volume":"272","author":"Klein","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2022.09.030_bib93","doi-asserted-by":"crossref","first-page":"22370","DOI":"10.1074\/jbc.M110.117465","article-title":"Two modes of b-receptor recognition are mediated by distinct epitopes on mouse and human interleukin-3","volume":"285","author":"Mirza","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2022.09.030_bib94","doi-asserted-by":"crossref","first-page":"23754","DOI":"10.1074\/jbc.270.40.23754","article-title":"Saturation mutagenesis of human interleukin-3","volume":"270","author":"Olins","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2022.09.030_bib95","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/blood.V87.1.83.83","article-title":"Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor a-chain and functions as a specific IL-3 receptor antagonist","volume":"87","author":"Sun","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib96","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/19420862.2015.1119352","article-title":"CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common \u03b2chain of the IL-3, GM-CSF and IL-5 receptors","volume":"8","author":"Panousis","year":"2016","journal-title":"MAbs"},{"key":"10.1016\/j.jaci.2022.09.030_bib97","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1182\/blood.V94.6.1943","article-title":"Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3 stimulation of human eosinophils by targeting the common cytokine binding site of their receptors","volume":"94","author":"Sun","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib98","doi-asserted-by":"crossref","first-page":"31680","DOI":"10.1016\/S0021-9258(18)31749-6","article-title":"Convergence of signaling by interleukin-3, granulocyte-macrophage colony-stimulating factor, and mast cell growth factor on JAK2 tyrosine kinase","volume":"269","author":"Brizzi","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2022.09.030_bib99","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood.V97.6.1662","article-title":"Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit mediate activation of Jak\/Stat signaling and differentiation","volume":"97","author":"Lilly","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib100","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V89.3.863","article-title":"Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony-stimulating factor","volume":"89","author":"Soldi","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib101","first-page":"4335","article-title":"JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane proximal region","volume":"14","author":"Quelle","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jaci.2022.09.030_bib102","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/nm.2991","article-title":"Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis","volume":"18","author":"Broxmeyer","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib103","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1182\/blood.V91.9.3182","article-title":"Interleukin-3-induced activation of the JAK\/STAT pathway is prolonged by proteasome inhibitors","volume":"91","author":"Callus","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib104","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.stem.2017.08.011","article-title":"Jak1 integrates cytokine sensing to regulate hematopoietic stem cell function and stress hematopoiesis","volume":"21","author":"Kleppe","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jaci.2022.09.030_bib105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jcb.20513","article-title":"Simultaneous activation of JAK1 and JAK2 confers IL-3 independent growth on Ba\/F3 pro-B cells","volume":"96","author":"Huang","year":"2005","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jaci.2022.09.030_bib106","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1182\/blood.V91.7.2264","article-title":"JAK2 and JAK1 constitutively associate with an interleukin-5 (IL-5) receptor alpha and betac subunit, respectively, and are activated upon IL-5 stimulation","volume":"91","author":"Ogata","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101513","article-title":"Messing with \u03b2c: a unique receptor with many goals","volume":"54","author":"Kan","year":"2021","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib108","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.abn8933","article-title":"Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation","volume":"376","author":"Glassman","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jaci.2022.09.030_bib109","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4049\/jimmunol.1801668","article-title":"Human eosinophils express a distinct gene expression program in response to IL-3 compared with common \u03b2-chain cytokines IL-5 and GM-CSF","volume":"203","author":"Nelson","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib110","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","article-title":"Chronic rhinosinusitis in Europe\u2014an underestimated disease. A\u00a0GA(2)LEN study","volume":"66","author":"Hastan","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.09.030_bib111","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1471-2458-12-204","article-title":"Global asthma prevalence in adults: findings from the cross-sectional world health survey","volume":"12","author":"To","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jaci.2022.09.030_bib112","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.molmed.2005.02.002","article-title":"The role of eosinophils in the pathogenesis of asthma","volume":"11","author":"Kay","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib113","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0196-0709(97)90003-X","article-title":"Interleukin-3 interleukin-5, and granulocyte-macrophage colony- stimulating factor expression in nasal polyps","volume":"18","author":"Allen","year":"1997","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.jaci.2022.09.030_bib114","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jaci.2004.12.1129","article-title":"Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids","volume":"115","author":"Deykin","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/ajrccm.161.1.9809100","article-title":"Changes in sputum eosinophils predict loss of asthma control","volume":"161","author":"Jatakanon","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib116","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/01.mlg.0000147917.43615.c0","article-title":"Molecular and cellular staging for the severity of chronic rhinosinusitis","volume":"114","author":"Kountakis","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2022.09.030_bib117","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4168\/aair.2019.11.3.394","article-title":"Serum levels of eosinophil-derived neurotoxin: a biomarker for asthma severity in adult asthmatics","volume":"11","author":"Lee","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2022.09.030_bib118","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2500\/ajra.2015.29.4231","article-title":"Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population","volume":"29","author":"Lou","year":"2015","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2022.09.030_bib119","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4193\/Rhino10.261","article-title":"Mucosal eosinophilia and recurrence of nasal polyps\u2014new classification of chronic rhinosinusitis","volume":"49","author":"Nakayama","year":"2011","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2022.09.030_bib120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1183\/09031936.00201813","article-title":"Importance of concomitant local and systemic eosinophilia in uncontrolled asthma","volume":"44","author":"Schleich","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2022.09.030_bib121","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","article-title":"Chronic rhinosinusitis with nasal polyps and asthma","volume":"9","author":"Laidlaw","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.09.030_bib122","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.2500\/ajra.2013.27.3958","article-title":"Accumulation of effector memory CD8+ T cells in nasal polyps","volume":"27","author":"Pant","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2022.09.030_bib123","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/all.12311","article-title":"CD8(+) T cells producing IL-3 and IL-5 in non-IgE-mediated eosinophilic diseases","volume":"68","author":"Stoeckle","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.09.030_bib124","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2015.07.007","article-title":"Barrier epithelial cells and the control of type 2 immunity","volume":"43","author":"Hammad","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.09.030_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.09.041","article-title":"Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways\u00a0hyperreactivity","volume":"129","author":"Barlow","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib126","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.immuni.2015.01.016","article-title":"The interleukin-33-p38 kinase axis confers memory T helper 2 cell pathogenicity in the airway","volume":"42","author":"Endo","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.09.030_bib127","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.4049\/jimmunol.181.7.4780","article-title":"IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4","volume":"181","author":"Kurowska-Stolarska","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088714","article-title":"A GM-CSF\/IL-33 pathway facilitates allergic airway responses to sub-threshold house dust mite exposure","volume":"9","author":"Llop-Guevara","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2022.09.030_bib129","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1172\/JCI116008","article-title":"Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics","volume":"90","author":"Broide","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.09.030_bib130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.174.3.745","article-title":"Granulocyte\/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils","volume":"174","author":"Kita","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib131","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1189\/jlb.0106046","article-title":"Strain-dependent resistance to allergen-induced lung pathophysiology in mice correlates with rate of apoptosis of lung-derived eosinophils","volume":"81","author":"Tumes","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2022.09.030_bib132","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.med.53.082901.103921","article-title":"The pathophysiology of asthma","volume":"53","author":"Maddox","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib133","article-title":"Role of the eosinophil in allergic reactions","volume":"22","author":"Weller","year":"1996","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.jaci.2022.09.030_bib134","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.immunol.17.1.255","article-title":"Immunologic basis of antigen-induced airway hyperresponsiveness","volume":"17","author":"Wills-Karp","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib135","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.4049\/jimmunol.167.6.3146","article-title":"Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function","volume":"167","author":"MacKenzie","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.01.019","article-title":"Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation","volume":"139","author":"Gevaert","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib137","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood-2007-01-071340","article-title":"Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus","volume":"110","author":"Phipps","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib138","article-title":"Th2 and eosinophil responses suppress inflammatory arthritis","volume":"7","author":"Chen","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2022.09.030_bib139","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1164\/rccm.201611-2234OC","article-title":"Mepolizumab attenuates airway eosinophil numbers, but not their functional phenotype, in asthma","volume":"196","author":"Kelly","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib140","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1182\/blood-2012-07-443424","article-title":"Use of 111-indium-labeled autologous eosinophils to establish the in\u00a0vivo kinetics of human eosinophils in healthy subjects","volume":"120","author":"Farahi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib141","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4168\/aair.2010.2.2.87","article-title":"Eosinophil survival and apoptosis in health and disease","volume":"2","author":"Park","year":"2010","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2022.09.030_bib142","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1165\/ajrcmb.20.1.3449","article-title":"CD34(+)\/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors","volume":"20","author":"Robinson","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2022.09.030_bib143","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4049\/jimmunol.170.1.537","article-title":"The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells","volume":"170","author":"Lamkhioued","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib144","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0091-6749(99)70291-5","article-title":"Increased progenitor cell proliferation in the peripheral blood of patients with bronchial asthma: the role of nitric oxide","volume":"104","author":"Wang","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib145","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.iac.2018.06.003","article-title":"Airway eosinophilopoietic and autoimmune mechanisms of eosinophilia in severe asthma","volume":"38","author":"Bhalla","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2022.09.030_bib146","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.200307-1004OC","article-title":"Sputum CD34+IL-5Ralpha+ cells increase after allergen: evidence for in situ eosinophilopoiesis","volume":"169","author":"Dorman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib147","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1164\/rccm.2108015","article-title":"Allergen-induced increases in bone marrow T lymphocytes and interleukin-5 expression in subjects with asthma","volume":"166","author":"Wood","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib148","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/cea.12695","article-title":"Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma","volume":"46","author":"Sehmi","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2022.09.030_bib149","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jaci.2004.09.022","article-title":"Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice","volume":"115","author":"Southam","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib150","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.4049\/jimmunol.164.3.1538","article-title":"Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor","volume":"164","author":"Cameron","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib151","doi-asserted-by":"crossref","first-page":"E2842","DOI":"10.1073\/pnas.1512600113","article-title":"Thy1+IL-7+ lymphatic endothelial cells in iBALT provide a survival niche for memory T-helper cells in allergic airway inflammation","volume":"113","author":"Shinoda","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.09.030_bib152","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2500\/ajra.2013.27.3880","article-title":"Sinus surgery and delivery method influence the effectiveness of topical corticosteroids for chronic rhinosinusitis: systematic review and meta-analysis","volume":"27","author":"Snidvongs","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2022.09.030_bib153","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.anai.2010.11.019","article-title":"Detection of immunological biomarkers correlated with asthma control and quality of life measurements in sera from chronic asthmatic patients","volume":"106","author":"Patil","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib154","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0091-6749(93)90118-Y","article-title":"Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma","volume":"92","author":"Robinson","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib155","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.4049\/jimmunol.180.11.7622","article-title":"Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challenge","volume":"180","author":"Johansson","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.821658","article-title":"An immunoregulatory role of interleukin-3 in allergic asthma","volume":"13","author":"Krammer","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib157","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1182\/blood-2012-06-330845","article-title":"The expanding role(s) of eosinophils in health and disease","volume":"120","author":"Jacobsen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib158","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1067\/mai.2000.107038","article-title":"Delayed eosinophil apoptosis in asthma","volume":"106","author":"Kankaanranta","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib159","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/cea.12876","article-title":"IL-3 up-regulates and activates human eosinophil CD32 and \u03b1M\u03b22 integrin causing degranulation","volume":"47","author":"Esnault","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2022.09.030_bib160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1034\/j.1398-9995.2003.00110.x","article-title":"Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis","volume":"58","author":"Gevaert","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.09.030_bib161","first-page":"429","article-title":"Essential mechanisms of differential activation of eosinophils by IL-3 compared to GM-CSF and IL-5","volume":"36","author":"Esnault","year":"2016","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib162","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.4049\/jimmunol.170.11.5359","volume":"170","author":"Gregory","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib163","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.4049\/jimmunol.160.9.4427","article-title":"Selective inhibition of IL-5 receptor alpha-chain gene transcription by IL-5, IL-3, and granulocyte-macrophage colony-stimulating factor in human blood eosinophils","volume":"160","author":"Wang","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib164","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaf9154","article-title":"Myosin light chains 9 and 12 are functional ligands for CD69 that regulate airway inflammation","volume":"1","author":"Hayashizaki","year":"2016","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib165","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.4049\/jimmunol.167.6.3443","article-title":"IL-3 induces down-regulation of CCR3 protein and mRNA in human eosinophils","volume":"167","author":"Dulkys","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib166","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1172\/JCI85664","article-title":"Lung-resident eosinophils represent a distinct regulatory eosinophil subset","volume":"126","author":"Mesnil","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.09.030_bib167","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1172\/JCI5809","article-title":"Regulation of TH1- and TH2-type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle","volume":"103","author":"Hakonarson","year":"1999","journal-title":"J Clin Invest"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2022.09.030_bib168","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000337756","article-title":"Alternaria fungus induces the production of GM-CSF, interleukin-6 and interleukin-8 and calcium signaling in human airway epithelium through protease-activated receptor 2","volume":"158","author":"Matsuwaki","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib169","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.4049\/jimmunol.175.8.5439","article-title":"Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils","volume":"175","author":"Inoue","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib170","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/infdis\/jiw054","article-title":"Role of granulocyte-macrophage colony-stimulating factor signaling in regulating neutrophil antifungal activity and the oxidative burst during respiratory fungal challenge","volume":"213","author":"Kasahara","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2022.09.030_bib171","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1189\/jlb.0112009","article-title":"Staphylococcus aureus directly activates eosinophils via platelet-activating factor receptor","volume":"92","author":"Hosoki","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2022.09.030_bib172","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jprot.2017.12.003","article-title":"Staphylococcus aureus controls interleukin-5 release in upper airway inflammation","volume":"180","author":"Bachert","year":"2018","journal-title":"J Proteomics"},{"key":"10.1016\/j.jaci.2022.09.030_bib173","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1146\/annurev-immunol-093019-125918","article-title":"Eosinophil knockout humans: uncovering the role of eosinophils through eosinophil-directed biological therapies","volume":"39","author":"Jacobsen","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib174","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/annrheumdis-2020-218019","article-title":"Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs","volume":"79","author":"Isaacs","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2022.09.030_bib175","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1111\/all.14297","article-title":"Human airway epithelial cells express a functional IL-5 receptor","volume":"75","author":"Barretto","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.09.030_bib176","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1165\/rcmb.2019-0214OC","article-title":"IL-5 exposure in utero increases lung nerve density and airway reactivity in adult offspring","volume":"62","author":"Lebold","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2022.09.030_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.08.044","article-title":"GM-CSF intrinsically controls eosinophil accumulation in the setting of allergic airway inflammation","volume":"143","author":"Nobs","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.12.638","article-title":"GM-CSF instigates a dendritic cell-T-cell inflammatory circuit that drives chronic asthma development","volume":"147","author":"Nobs","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib179","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1814620","article-title":"Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response","volume":"9","author":"Mashima","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jaci.2022.09.030_bib180","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1038\/s41467-018-04985-0","article-title":"Human in\u00a0vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway","volume":"9","author":"Tang-Huau","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2022.09.030_bib181","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1182\/blood.V99.3.993","article-title":"Interleukin-3 and interferon beta cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties","volume":"99","author":"Buelens","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib182","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.4049\/jimmunol.168.12.6199","article-title":"A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern","volume":"168","author":"Ebner","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib183","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1183\/09031936.97.10040846","article-title":"Increased bronchoalveolar granulocytes and granulocyte\/macrophage colony-stimulating factor during exacerbations of chronic bronchitis","volume":"10","author":"Balbi","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2022.09.030_bib184","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1164\/rccm.200912-1794OC","article-title":"Neutralizing granulocyte\/macrophage colony-stimulating factor inhibits cigarette smoke-induced lung inflammation","volume":"182","author":"Vlahos","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib185","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/resp.14297","article-title":"Targeting the human \u03b2c receptor inhibits inflammatory myeloid cells and lung injury caused by acute cigarette smoke exposure","volume":"27","author":"Fung","year":"2022","journal-title":"Respirology"},{"key":"10.1016\/j.jaci.2022.09.030_bib186","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1183\/09031936.00162414","article-title":"Eosinophilic inflammation in COPD: prevalence and clinical characteristics","volume":"44","author":"Singh","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2022.09.030_bib187","first-page":"39","article-title":"Eosinophilic airway inflammation in COPD","volume":"1","author":"Saha","year":"2006","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaci.2022.09.030_bib188","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","article-title":"Mepolizumab for eosinophilic chronic obstructive pulmonary disease","volume":"377","author":"Pavord","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib189","doi-asserted-by":"crossref","first-page":"a022293","DOI":"10.1101\/cshperspect.a022293","article-title":"TGF-\u03b21 signaling and tissue fibrosis","volume":"10","author":"Kim","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jaci.2022.09.030_bib190","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1165\/ajrcmb.17.3.2733","article-title":"Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma","volume":"17","author":"Minshall","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2022.09.030_bib191","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/BF02896165","article-title":"IL-5 up-regulates the expression of TGF-beta1 in human blood eosinophils in\u00a0vitro","volume":"25","author":"Huang","year":"2005","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.jaci.2022.09.030_bib192","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1172\/JCI17974","article-title":"Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics","volume":"112","author":"Flood-Page","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.09.030_bib193","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1067\/mai.2000.110556","article-title":"Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects","volume":"106","author":"Chu","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib194","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1067\/mai.2001.111928","article-title":"Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis","volume":"107","author":"Hoshino","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib195","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm1105","article-title":"Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung","volume":"10","author":"Lee","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib196","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1165\/ajrcmb.17.1.2796","article-title":"Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5","volume":"17","author":"Horiuchi","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2022.09.030_bib197","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1046\/j.1365-2745.2002.01491.x","article-title":"The involvement of matrix metalloproteinases in basement membrane injury in a murine model of acute allergic airway inflammation","volume":"32","author":"Kumagai","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2022.09.030_bib198","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1165\/ajrcmb.16.3.9070604","article-title":"Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation","volume":"16","author":"Ohno","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2022.09.030_bib199","doi-asserted-by":"crossref","first-page":"11137","DOI":"10.1073\/pnas.90.23.11137","article-title":"The receptor for interleukin 3 is selectively induced in human endothelial cells by tumor necrosis factor alpha and potentiates interleukin 8 secretion and neutrophil transmigration","volume":"90","author":"Korpelainen","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.09.030_bib200","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1172\/JCI119496","article-title":"Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis: implications for sustained dendritic cell activation in the skin","volume":"99","author":"Pastore","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.09.030_bib201","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0091-6749(98)70093-4","article-title":"In\u00a0vivo expression of cytokine receptor mRNA in atopic dermatitis","volume":"102","author":"Taha","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib202","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fimmu.2017.01388","article-title":"GM-CSF monocyte-derived cells and Langerhans cells as part of the dendritic cell family","volume":"8","author":"Lutz","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib203","first-page":"778","article-title":"Involvement of interleukin-3 in delayed-type hypersensitivity","volume":"91","author":"Mach","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib204","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood.V97.4.922","article-title":"Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity","volume":"97","author":"Gillessen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib205","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1038\/ncomms3847","article-title":"Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade","volume":"4","author":"Leyva-Castillo","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2022.09.030_bib206","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210639","article-title":"ACC1-expressing pathogenic T helper 2 cell populations facilitate lung and skin inflammation in mice","volume":"218","author":"Nakajima","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib207","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jid.2021.07.183","article-title":"Targeting the human \u03b2c receptor inhibits contact dermatitis in a transgenic mouse model","volume":"142","author":"Yip","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2022.09.030_bib208","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ki.2015.196","article-title":"IL-3 contributes to development of lupus nephritis in MRL\/lpr mice","volume":"88","author":"Renner","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.jaci.2022.09.030_bib209","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000236414","article-title":"Interleukin-3 immunoassay in systemic lupus erythematosus patients: preliminary data","volume":"100","author":"Fishman","year":"1993","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib210","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1182\/blood.V124.21.120.120","article-title":"First-in man, phase 1 study of CSL362 (anti-IL3R\u03b1\/anti-CD123 monoclonal antibody) in patients with CD123+ acute myeloid leukemia (AML) in CR at high risk for early relapse","volume":"124","author":"Smith","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib211","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1097","article-title":"A potential association between IL-3 and type I and III interferons in systemic lupus erythematosus","volume":"8","author":"Oon","year":"2019","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.jaci.2022.09.030_bib212","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1038\/cti.2016.26","article-title":"Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway","volume":"5","author":"Oon","year":"2016","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.jaci.2022.09.030_bib213","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2009.04.018","article-title":"Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells","volume":"5","author":"Jin","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jaci.2022.09.030_bib214","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.leu.2401903","article-title":"The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells","volume":"14","author":"Jordan","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2022.09.030_bib215","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1182\/blood-2002-03-0852","article-title":"Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis","volume":"100","author":"Testa","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib216","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3324\/haematol.2011.047894","article-title":"High levels of CD34+CD38low\/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study","volume":"96","author":"Vergez","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2022.09.030_bib217","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/bloodadvances.2016002931","article-title":"High CD123 levels enhance proliferation in response to IL-3, but reduce chemotaxis by downregulating CXCR4 expression","volume":"1","author":"Wittwer","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaci.2022.09.030_bib218","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3324\/haematol.2014.111740","article-title":"In\u00a0vivo and in\u00a0vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent","volume":"100","author":"Angelot-Delettre","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2022.09.030_bib219","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/blood-2014-04-566737","article-title":"Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients","volume":"124","author":"Frankel","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib220","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/leu.2015.16","article-title":"Aberrant expression of CD123 (interleukin-3 receptor-a) on neoplastic mast cells","volume":"29","author":"Pardanani","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2022.09.030_bib221","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/leu.2015.348","article-title":"CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic value","volume":"30","author":"Pardanani","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2022.09.030_bib222","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood-2012-12-475194","article-title":"Monoclonal antibody targeting of IL-3 receptor a with CSL362 effectively depletes CML progenitor and stem cells","volume":"123","author":"Nievergall","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib223","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1182\/blood.V74.8.2769.2769","article-title":"Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor: simultaneous induction of interleukin-6 release and flare-up of the arthritis","volume":"74","author":"Hazenberg","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib224","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ng.2231","article-title":"Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population","volume":"44","author":"Okada","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2022.09.030_bib225","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ni.2027","article-title":"ROR\u03b3t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation","volume":"12","author":"Codarri","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib226","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.it.2015.08.004","article-title":"GM-CSF in neuroinflammation: licensing myeloid cells for tissue damage","volume":"36","author":"Croxford","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib227","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ni.2031","article-title":"The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF","volume":"12","author":"El-Behi","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib228","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/cr.2014.154","article-title":"STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation","volume":"24","author":"Sheng","year":"2014","journal-title":"Cell Res"},{"key":"10.1016\/j.jaci.2022.09.030_bib229","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1212\/NXI.0000000000000117","article-title":"Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis","volume":"2","author":"Constantinescu","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jaci.2022.09.030_bib230","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12016-019-08749-6","article-title":"Eosinophilic esophagitis: the potential role of biologics in its treatment","volume":"59","author":"Choudhury","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2 Suppl","key":"10.1016\/j.jaci.2022.09.030_bib231","doi-asserted-by":"crossref","first-page":"AB234","DOI":"10.1016\/j.jaci.2015.12.949","article-title":"Long-term safety and efficacy of reslizumab in children and adolescents with eosinophilic esophagitis: a review of 477 doses in 12 children over 7 years","volume":"137","author":"Markowitz","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib232","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2022.09.030_bib233","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2022.09.030_bib234","article-title":"Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: the role of GM-CSF","author":"Calabrese","year":"2020","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib235","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3389\/fimmu.2020.01625","article-title":"Targeting GM-CSF in COVID-19 pneumonia: rationale and strategies","volume":"11","author":"Bonaventura","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib236","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf6692","article-title":"Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients","volume":"6","author":"Zhao","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib237","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/leu.2014.128","article-title":"Targeting of acute myeloid leukemia in\u00a0vitro and in\u00a0vivo with an anti-CD123 mAb engineered for optimal ADCC","volume":"28","author":"Busfield","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2022.09.030_bib238","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/s41375-019-0645-z","article-title":"Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents","volume":"34","author":"Kubasch","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2022.09.030_bib239","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41375-020-0773-5","article-title":"Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2\/3 study","volume":"35","author":"Montesinos","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2022.09.030_bib240","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1182\/blood.2020007732","article-title":"Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia","volume":"137","author":"Uy","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2022.09.030_bib241","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/10428190701799035","article-title":"Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia","volume":"49","author":"Frankel","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaci.2022.09.030_bib242","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","article-title":"Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm","volume":"380","author":"Pemmaraju","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib243","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1158\/1078-0432.CCR-19-2329","article-title":"FDA approval summary: tagraxofusp-erzs for treatment of blastic plasmacytoid dendritic cell neoplasm","volume":"26","author":"Jen","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2022.09.030_bib244","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1182\/bloodadvances.2019000173","article-title":"Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm","volume":"4","author":"Pemmaraju","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaci.2022.09.030_bib245","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/bcp.15002","article-title":"A phase 1 study of the long-acting anti-IL-5 monoclonal antibody GSK3511294 in patients with asthma","volume":"88","author":"Singh","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2022.09.030_bib246","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2022.09.030_bib247","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","article-title":"Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway","volume":"167","author":"Flood-Page","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib248","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib249","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1111\/all.15334","article-title":"Covid-19 in the absence of eosinophils: the outcome of confirmed SARS-COV-2 infection whilst on treatment with benralizumab","volume":"77","author":"Francis","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.09.030_bib250","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jaci.2022.03.025","article-title":"Eosinophil-mediated suppression and anti-IL-5 enhancement of plasmacytoid dendritic cell interferon responses in asthma","volume":"150","author":"Dill-McFarland","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib251","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/art.40420","article-title":"Mavrilimumab, a fully human granulocyte-macrophage colony-stimulating factor receptor \u03b1monoclonal antibody: long-term safety and efficacy in patients with rheumatoid arthritis","volume":"70","author":"Burmester","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2022.09.030_bib252","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/art.40323","article-title":"A randomized phase IIb study of mavrilimumab and golimumab in rheumatoid arthritis","volume":"70","author":"Weinblatt","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2022.09.030_bib253","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13075-019-1879-x","volume":"21","author":"Taylor","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2022.09.030_bib254","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1016\/S2665-9913(20)30229-0","article-title":"Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study","volume":"2","author":"Buckley","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaci.2022.09.030_bib255","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1016\/S2665-9913(20)30224-1","article-title":"MRI of the joint and evaluation of the granulocyte\u2013macrophage colony-stimulating factor\u2013CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study","volume":"2","author":"Genovese","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaci.2022.09.030_bib256","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1016\/S2665-9913(20)30170-3","article-title":"GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study","volume":"2","author":"De Luca","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaci.2022.09.030_bib257","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.mayocp.2020.08.038","article-title":"GM-CSF neutralization with lenzilumab in severe COVID-19 pneumonia: a case-cohort study","volume":"95","author":"Temesgen","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaci.2022.09.030_bib258","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S2213-2600(21)00494-X","article-title":"Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial","volume":"10","author":"Temesgen","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib259","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S2213-2600(21)00539-7","article-title":"Stimulating severe COVID-19: the potential role of GM-CSF antagonism","volume":"10","author":"Leavis","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2022.09.030_bib260","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0167-5699(92)90025-3","article-title":"GM-CSF, IL-3 and IL-5: cross-competition on human haemopoietic cells","volume":"13","author":"Lopez","year":"1992","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaci.2022.09.030_bib261","doi-asserted-by":"crossref","first-page":"24741","DOI":"10.1016\/S0021-9258(18)54292-7","article-title":"Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils","volume":"266","author":"Lopez","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2022.09.030_bib262","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.it.2017.12.003","article-title":"Immune cytokines and their receptors in inflammatory pain","volume":"39","author":"Cook","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2022.09.030_bib263","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1016\/S2665-9913(21)00146-6","article-title":"Targeting GM CSF in rheumatological conditions: risk of PAP\u2014authors\u2019 reply","volume":"3","author":"Genovese","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaci.2022.09.030_bib264","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1016\/S2665-9913(20)30171-5","article-title":"Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial","volume":"2","author":"Schett","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaci.2022.09.030_bib265","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1042\/CS20210713","article-title":"Chronic pharmacological antagonism of the GM-CSF receptor in mice does not replicate the pulmonary alveolar proteinosis phenotype but does alter lung surfactant turnover","volume":"135","author":"Corkill","year":"2021","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jaci.2022.09.030_bib266","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1080\/19420862.2016.1215790","article-title":"Pulmonary pharmacodynamics of an anti-GM-CSFR\u03b1 antibody enables therapeutic dosing that limits exposure in the lung","volume":"8","author":"Campbell","year":"2016","journal-title":"MAbs"},{"key":"10.1016\/j.jaci.2022.09.030_bib267","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/all.14041","article-title":"Anti-\u03b2c mAb CSL311 inhibits human nasal polyp pathophysiology in a humanized mouse xenograft model","volume":"75","author":"Yip","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.09.030_bib268","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41419-022-04589-z","article-title":"Blocking the human common beta subunit of the GM-CSF, IL-5 and IL-3 receptors markedly reduces hyperinflammation in ARDS models","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922013392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922013392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:39:25Z","timestamp":1758793165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674922013392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":268,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0091674922013392"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2022.09.030","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translating the biology of \u03b2 common receptor-engaging cytokines into clinical medicine","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}